TCEA1 Suppresses Acute Promyelocytic Leukemia by Upregulating C/EBPε and IRF8
International Journal of Molecular Sciences · 15.06.2026 · 27 (12) · 5380
DOI: 10.3390/ijms27125380 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.06.2026. Verfasst von Taomei Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, Interferon Regulatory Factors. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Provincial Science and Technology Department, Guizhou University of Traditional Chinese Medicine, Guizhou Provincial Basic Research Program.
Abstract (Originalsprache)
We previously showed that TCEA1 deficiency in myeloid cells promotes proliferation, impairs differentiation and inhibits apoptosis, but its role and underlying mechanism in acute myeloid leukemia (AML) are unknown. Here, in NB-4 cells, an M3 subtype of AML, TCEA1 overexpression suppressed proliferation (p < 0.001), induced S-phase arrest (from 35.35% to 19.47%, p < 0.001), increased apoptosis (from 10.37% to 23.5%, p < 0.001), and promoted differentiation. Mechanistically, TCEA1 overexpression upregulated C/EBPε and IRF8 at the mRNA and protein levels; conversely, TCEA1 knockdown downregulated both. Rescue experiments in TCEA1 knockdown 32Dcl3 cells showed that ectopic C/EBPε or IRF8 reversed the uncontrolled proliferation, blocked apoptosis, and impaired differentiation. In xenograft mouse models, TCEA1 overexpression reduced leukemic infiltration in the bone marrow, spleen, and liver; extended overall survival; and elevated C/EBPε and IRF8 expression in vivo. Analysis of public APL datasets revealed that high TCEA1 expression is associated with a favorable prognosis (HR = 0.43, 95% CI: 0.2–0.93, logrank p = 0.028). Collectively, our findings demonstrate that TCEA1 suppresses proliferation, promotes apoptosis and differentiation, and attenuates disease progression by upregulating C/EBPε and IRF8, positioning this regulatory mechanism as a potential therapeutic target and prognostic biomarker for this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
- Guizhou Center for Disease Control and Prevention, Guiyang 550004, China.
Förderung
- Guizhou Provincial Science and Technology Department
- Guizhou University of Traditional Chinese Medicine
- Guizhou Provincial Basic Research Program
- Doctor Startup Fund of Guizhou University of Traditional Chinese Medicine
Zitieren
APA
Yang, T., Wan, Y., Chu, C., & Chen, X. (2026). TCEA1 Suppresses Acute Promyelocytic Leukemia by Upregulating C/EBPε and IRF8. International Journal of Molecular Sciences, 27(12), 5380. https://doi.org/10.3390/ijms27125380
Vancouver
Yang T, Wan Y, Chu C, Chen X. TCEA1 Suppresses Acute Promyelocytic Leukemia by Upregulating C/EBPε and IRF8. International Journal of Molecular Sciences. 2026;27(12):5380. doi:10.3390/ijms27125380
BibTeX
@article{Yang2026,
author = {Yang, Taomei and Wan, Yonghu and Chu, Chunwei and Chen, Xiangyun},
title = {TCEA1 Suppresses Acute Promyelocytic Leukemia by Upregulating C/EBPε and IRF8},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5380},
doi = {10.3390/ijms27125380}
}
EUVIMED